Jan 15 (Reuters) - Glenmark Pharmaceuticals Ltd:
* GETS PERMISSION BY CENTRAL DRUGS STANDARD CONTROL ORGANIZATION FOR PHASE IIB DOSE RANGE FINDING STUDY FOR GRC 27864 Source text - bit.ly/2mEqR6R Further company coverage:
 